BDBM307571 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)- 5-(4-(6-fluoropyridin-2-yl)oxazol-2-yl)-2- methylpiperidin-1-yl)methanone::US10150751, Example 4

SMILES C[C@@H]1C[C@H](CN1C(=O)c1ccsc1-c1ncccn1)Nc1cc(OCC(F)F)ccn1

InChI Key InChIKey=JSEVXLVIUNEVRV-ZIAGYGMSSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 307571   

TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM307571((2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)- 5-(4-(6...)
Affinity DataIC50: >1.00E+4nMAssay Description: All reagents were from GIBCO-Invitrogen Corp. The seeded plates are incubated overnight at 37° C. and 5% CO2. Ala-6,12 human orexin-A as the agonist...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM307571((2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)- 5-(4-(6...)
Affinity DataIC50:  520nMAssay Description: All reagents were from GIBCO-Invitrogen Corp. The seeded plates are incubated overnight at 37° C. and 5% CO2. Ala-6,12 human orexin-A as the agonist...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent